Review

Nature Reviews Cancer 4, 948-955 (December 2004) | doi:10.1038/nrc1501

Focus on: kinases

Regulation of the cytoskeleton: an oncogenic function for cdk inhibitors?

Arnaud Besson1, Richard K. Assoian2 & James M. Roberts1,3  About the authors

Top

Cyclin-dependent kinase inhibitors (CKIs) are well known inhibitors of cell proliferation. Their activity is disrupted in many tumour types. Recent studies show that some of these proteins have interesting alternative functions, acting in the cytoplasm to regulate Rho signalling and thereby controlling cytoskeletal organization and cell migration. The upregulation of CKIs in the cytoplasm of many cancer cells indicates that although loss of nuclear CKIs is important for cancer cell proliferation, gain of cytoplasmic CKI function might be involved in tumour invasion and metastasis.

Author affiliations

  1. Howard Hughes Medical Institute, Fred Hutchinson Cancer Research Center, Division of Basic Science, Seattle, Washington 98109, USA.
  2. Department of Pharmacology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, USA.
  3. Fred Hutchinson Cancer Research Center, Division of Basic Science, Mail stop A3-020, 1100 Fairview Avenue North, Seattle, Washington 98109, USA.

Correspondence to: James M. Roberts1,3 Email: jroberts@fhcrc.org

MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated.

NEWS AND VIEWS

Cdk5 checks p27 kip1 in neuronal migration

Nature Cell Biology News and Views (01 Jan 2006)

Cancer Kip moving

Nature News and Views (15 Apr 2004)

See all 4 matches for News And Views

Extra navigation

Subscribe

Subscribe to Nature Reviews Cancer

Search PubMed for

naturejobs

natureproducts


Advertisement